Connection

MOREY HAYMOND to Keto Acids

This is a "connection" page, showing publications MOREY HAYMOND has written about Keto Acids.
Connection Strength

0.904
  1. Tritium and 14C isotope effects using tracers of leucine and alpha-ketoisocaproate. Eur J Clin Invest. 1993 Jun; 23(6):350-5.
    View in: PubMed
    Score: 0.108
  2. Comparison of precursor pools with leucine, alpha-ketoisocaproate, and phenylalanine tracers used to measure splanchnic protein synthesis in man. Metabolism. 1993 Jun; 42(6):691-5.
    View in: PubMed
    Score: 0.108
  3. Determination of leucine and alpha-ketoisocaproic acid concentrations and specific activity in plasma and leucine specific activities in proteins using high-performance liquid chromatography. J Chromatogr. 1989 Oct 27; 495:81-94.
    View in: PubMed
    Score: 0.084
  4. Measurement of branched chain amino acids and branched chain alpha-ketoacids in plasma by high-performance liquid chromatography. J Chromatogr. 1982 Oct 08; 232(1):170-5.
    View in: PubMed
    Score: 0.051
  5. Regulation of alpha-ketoisocaproate binding to albumin in vivo by free fatty acids. Am J Physiol. 1982 Jan; 242(1):E67-71.
    View in: PubMed
    Score: 0.049
  6. Effects of fasting on flux and interconversion of leucine and alpha-ketoisocaproate in vivo. Am J Physiol. 1981 Jul; 241(1):E72-5.
    View in: PubMed
    Score: 0.047
  7. Measurement of plasma alpha-ketoisocaproate concentrations and specific radioactivity by high-performance liquid chromatography. Anal Biochem. 1981 Jan 15; 110(2):389-92.
    View in: PubMed
    Score: 0.046
  8. Effect of parenteral administration of short-chain triglycerides on leucine metabolism. Am J Clin Nutr. 1993 Dec; 58(6):912-6.
    View in: PubMed
    Score: 0.028
  9. Growth hormone and lean tissue catabolism during long-term glucocorticoid treatment. Clin Endocrinol (Oxf). 1992 Feb; 36(2):161-4.
    View in: PubMed
    Score: 0.025
  10. Plasma pool source for fibrinogen synthesis in postabsorptive conscious dogs. Am J Physiol. 1991 Apr; 260(4 Pt 1):E581-7.
    View in: PubMed
    Score: 0.023
  11. Protein metabolism in obesity: effects of body fat distribution and hyperinsulinemia on leucine turnover. Am J Clin Nutr. 1991 Jan; 53(1):172-6.
    View in: PubMed
    Score: 0.023
  12. Differential effects of prednisone and growth hormone on fuel metabolism and insulin antagonism in humans. Diabetes. 1991 Jan; 40(1):141-9.
    View in: PubMed
    Score: 0.023
  13. Human growth hormone prevents the protein catabolic side effects of prednisone in humans. J Clin Invest. 1990 Jul; 86(1):265-72.
    View in: PubMed
    Score: 0.022
  14. Glucocorticosteroids increase leucine oxidation and impair leucine balance in humans. Am J Physiol. 1989 Nov; 257(5 Pt 1):E712-21.
    View in: PubMed
    Score: 0.021
  15. Plasma reciprocal pool specific activity predicts that of intracellular free leucine for protein synthesis. Am J Physiol. 1989 Sep; 257(3 Pt 1):E385-99.
    View in: PubMed
    Score: 0.021
  16. Determination of plasma concentrations and 3H-specific activity of phenylalanine in plasma using high-performance liquid chromatography. J Chromatogr. 1989 Jul 21; 491(2):410-7.
    View in: PubMed
    Score: 0.021
  17. Effects of acute metabolic acidosis and alkalosis on leucine metabolism in conscious dogs. Diabetes. 1989 Jul; 38(7):847-53.
    View in: PubMed
    Score: 0.020
  18. Preservation of insulin effects on glucose production and proteolysis during fasting. Am J Physiol. 1988 Jun; 254(6 Pt 1):E700-7.
    View in: PubMed
    Score: 0.019
  19. Effects of leucine, isoleucine, or threonine infusion on leucine metabolism in humans. Am J Physiol. 1987 Oct; 253(4 Pt 1):E428-34.
    View in: PubMed
    Score: 0.018
  20. Effect of a protein synthetic inhibitor on in vivo estimates of protein synthesis in dogs. Am J Physiol. 1987 May; 252(5 Pt 1):E595-8.
    View in: PubMed
    Score: 0.018
  21. Trioctanoin infusion increases in vivo leucine oxidation: a lesson in isotope modeling. Am J Physiol. 1986 Sep; 251(3 Pt 1):E343-8.
    View in: PubMed
    Score: 0.017
  22. Changes in leucine kinetics during meal absorption: effects of dietary leucine availability. Am J Physiol. 1986 Jun; 250(6 Pt 1):E695-701.
    View in: PubMed
    Score: 0.017
  23. Inverse relationship of leucine flux and oxidation to free fatty acid availability in vivo. J Clin Invest. 1986 Feb; 77(2):575-81.
    View in: PubMed
    Score: 0.016
  24. Use of reciprocal pool specific activities to model leucine metabolism in humans. Am J Physiol. 1985 Dec; 249(6 Pt 1):E646-50.
    View in: PubMed
    Score: 0.016
  25. Apparent decreased oxidation and turnover of leucine during infusion of medium-chain triglycerides. Am J Physiol. 1985 Aug; 249(2 Pt 1):E175-82.
    View in: PubMed
    Score: 0.016
  26. Effects of [15N]leucine infused at low rates on leucine metabolism in humans. Am J Physiol. 1985 Jul; 249(1 Pt 1):E121-30.
    View in: PubMed
    Score: 0.016
  27. Recycling of an amino acid label with prolonged isotope infusion: implications for kinetic studies. Am J Physiol. 1985 Apr; 248(4 Pt 1):E482-7.
    View in: PubMed
    Score: 0.015
  28. Use of t-butyldimethylsilylation in the gas chromatographic/mass spectrometric analysis of physiologic compounds found in plasma using electron-impact ionization. Anal Biochem. 1984 Aug 15; 141(1):101-9.
    View in: PubMed
    Score: 0.015
  29. Effect of insulin and plasma amino acid concentrations on leucine metabolism in man. Role of substrate availability on estimates of whole body protein synthesis. J Clin Invest. 1987 Dec; 80(6):1784-93.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.